Determinants of coprescription of anxiolytics with antidepressants in general practice

Canadian Journal of Psychiatry

Volumn 53, Issue 2, 2008, Pages 94-103

  Verger, Pierre ^a,c   Saliba, Bérengère ^a   Rouillon, Frédéric ^b   Kovess Masféty, Viviane ^b   Villani, Patrick ^a   Bouvenot, Gilles ^a   Lovell, Anne ^a  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

Author keywords

Anti anxiety agents; Antidepressive agents; Depression; Family practice; Multilevel model; Practice guidelines

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL PRACTICE; DRUG INDICATION; FEMALE; FRANCE; GENERAL PRACTICE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NORMAL HUMAN; PRESCRIPTION; PROFESSIONAL KNOWLEDGE; QUESTIONNAIRE; SUICIDAL IDEATION;

EID: 39649087145     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370805300204     Document Type: Article

References (40)

1. Bartels SJ, Horn S, Sharkey P, et al. Treatment of depression in older primary care patients in health maintenance organizations. Int J Psychiatry Med. 1997;27(3):215-231.
2. Kirby M, Denihan A, Bruce I, et al. Benzodiazepine use among the elderly in the community. Int J Geriatr Psychiatry. 1999;14(4):280-284.
3. Simon GE, VonKorff M, Barlow W, et al. Predictors of chronic benzodiazepine use in a health maintenance organization sample. J Clin Epidemiol. 1996;49(9):1067-1073.
4. Valenstein M, Taylor KK, Austin K, et al. Benzodiazepine use among depressed patients treated in mental health settings. Am J Psychiatry. 2004;161(4):654-661.
5. Rihmer Z, Akiskal H. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. J Affect Disord. 2006;94(1-3):3-13.
6. Physicians' Desk Reference. Montvale (NJ): Thomson Medical; 2004.
7. Vidal. Le dictionnaire. Fiches médicaments. Issy-les-Moulineaux (FR): Vidal; 2006.
8. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. Am J Psychiatry. 2000;157(4 Suppl):1-45.
9. Kennedy SH, Lam RW, Morris B. Clinical guidelines for depressive disorders. Summary of recommendations relevant to family physicians. Can Fam Physician. 2003;49:489.
10. Birkenhager TK, Moleman P, Nolen WA. Benzodiazepines for depression? A review of the literature. Int Clin Psychopharmacol. 1995;10(3):181-195.
11. Nutt DJ, Mendelson WB. Bailliere's clinical psychiatry: hypnotics and anxiolytics. London (GB): Bailliere Tindall; 1995.
12. Furukawa TA, Streiner DL, Young LT. Is antidepressant-benzodiazepine combination therapy clinically more useful? A meta-analytic study. J Affect Disord. 2001;65(2):173-177.
13. Hylan TR, Crown WH, Meneades L, et al. SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis. Med Care. 1999;37(4 Suppl Lilly):AS36-AS44.
14. Melfi CA, Chawla AJ, Croghan TW, et al. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry. 1998;55(12):1128-1132.
15. Woods JH, Katz JL, Winger G. Benzodiazepines: use, abuse, and consequences. Pharmacol Rev. 1992;44(2):151-347.
16. Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry. 2002;63(9):817-825.
17. Alonso J, Angermeyer MC, Bernert S, et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004(420):55-64.
18. Kisely S, Linden M, Bellantuono C, et al. Why are patients prescribed psychotropic drugs by general practitioners? Results of an international study. Psychol Med. 2000;30(5):1217-1225.
19. Goldberg D, Huxley P. Mental illness in the community. The pathway to psychiatric care. New York (NY) and London (GB): Tavistock; 1980.
20. Verger P, Aulagnier M, Souville M, et al. Women with disabilities: general practitioners and breast cancer screening. Am J Prev Med. 2005;28(2):215-220.
21. Verger P, Brabis PA, Kovess V, et al. Determinants of early identification of suicidal ideation in patients treated with antidepressants or anxiolytics in general practice: a multilevel analysis. J Affect Disord. 2007;99:253-257.
22. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington (DC): American Psychiatric Association; 1994.
23. Razavi D, Delvaux N, Farvacques C, et al. Validation de la version française du HADS dans une population de patients cancéreux hospitalisés. Revue de Psychologie Appliquée. 1989;39:295-308.
24. Kovess V, Fournier L, Lesage A, et al. Two validation studies of the CIDIS: a simplified version of the CIDI. Psychiatric Networks. 2001;4(1):10-24.
25. Leplège A, Ecosse E, Pouchot J, et al. Le questionnaire MOS SF-36 manuel de l'utilisateur et guide d'interprétation des scores. Paris (FR): Estem; 2001.
26. Rueff B, Crnac J, Darne B. [Detection of alcoholic patients using the systematic CAGE autoquestionnaire. In out patients]. Presse Med. 1989;18(33):1654-1656.
27. Collet L, Cottraux J. The shortened Beck depression inventory (13 items). Study of the concurrent validity with the Hamilton scale and Widlocher's retardation scale. Encephale. 1986;12(2):77-79.
28. Goldstein H. Multilevel statistical models. London (GB): Edward Arnold; 1995.
29. Wilson AD. Consultation length: general practitioners' attitudes and practices. Br Med J (Clin Res Ed). 1985;290(6478):1322-1324.
30. Bensing JM, van den Brink-Muinen A, de Bakker DH. Gender differences in practice style: a Dutch study of general practitioners. Med Care. 1993;31(3):219-229.
31. Aulagnier M, Verger P, Ravaud JF, et al. General practitioners' attitudes towards patients with disabilities: the need for training and support. Disabil Rehabil. 2005;27(22):1343-1352.
32. ANAES. Prise en charge d'un épisode dépressif isolé de l'adulte en ambulatoire. Paris (FR): Agence Nationale d'Accréditation et d'Evaluation en Santé; 2002. p 92.
33. AFSSAPS. Bon usage des médicaments antidépresseurs dans le traitement des troubles dépressifs et des troubles anxieux chez l'adulte. Recommandations. Saint Denis (FR): Agence Française de Sécurité Sanitaire des produits de santé; 2006. p 17.
34. Devane CL, Chiao E, Franklin M, et al. Anxiety disorders in the 21st century: status, challenges, opportunities, and comorbidity with depression. Am J Manag Care. 2005;11(12 Suppl):S344-S353.
35. Nutt D. Treatment of depression and concomitant anxiety. Eur Neuropsychopharmacol. 2000;10 Suppl 4:S433-S437.
36. Culpepper L, Davidson JR, Dietrich AJ, et al. Suicidality as a possible side effect of antidepressant treatment. Prim Care Companion J Clin Psychiatry. 2004;6(2):79-86.
37. Fergusson D, Doucette S, Glass KC, et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ. 2005;330(7488):396.
38. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ. 2005;330(7488):385.
39. CPA position statement. Prescribing antidepressants for depression in 2005: recent concerns and recommendations. Can J Psychiatry. 2004;49(12):1-6.
40. McAvoy BR, Kaner EF. General practice postal surveys: a questionnaire too far? BMJ. 1996;313(7059):732-3; discussion 733-734.